載入...
Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition
Abnormal activation of the mammalian target of rapamycin (mTOR) signaling pathway has been observed in a variety of human cancers. Therefore, targeting of the mTOR pathway is an attractive strategy for cancer treatment and several mTOR inhibitors, including AZD8055 (AZD), a novel dual mTORC1/2 inhib...
Na minha lista:
| 發表在: | Stem Cells Int |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Publishing Corporation
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4499403/ https://ncbi.nlm.nih.gov/pubmed/26221145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/561404 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|